Ionis Pharmaceuticals (IONS) PT Raised to $115 at Barclays
Tweet
Share
E-mailGet Alerts IONS Hot Sheet
Price: $58.13 -5.22%
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
17 Buy, 11 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
Barclays analyst Eliana Merle raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $115.00 (from $106.00) while maintaining a Overweight rating.
You May Also Be Interested In
- FDA approves Ionis Pharma's therapy to treat rare genetic disorder
- JPMorgan Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
- CIENA (CIEN) PT Lowered to $520 at Needham, 'We would be buyers on weakness'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
